Related Experiment Videos

Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship to thrombosis

Insights

A novel abnormal plasminogen, Frankfurt I, was found in a patient with deep vein thrombosis, despite normal clotting tests. This defect involves reduced functional activity due to missing active sites in plasminogen molecules.

Area of Science:

  • Hematology
  • Molecular Biology
  • Biochemistry

Background:

  • Recurrent deep vein thrombosis (DVT) can stem from defects in the fibrinolytic system.
  • Plasminogen is a key protein in fibrinolysis, responsible for generating plasmin to break down blood clots.

Observation:

  • A patient with recurrent DVT presented with normal hemostasis but low plasma plasmin generation rates.
  • Analysis revealed that approximately half of the plasminogen molecules in the patient (and his mother) lacked functional active sites.

Findings:

  • The abnormal plasminogen, termed Frankfurt I, exhibited normal size and shape but had increased negative charge compared to normal plasminogen.
  • Electrophoretic and isoelectric focusing studies indicated a functional abnormality related to the absence of active sites in 50% of the plasminogen molecules.
  • The generated plasmin was unstable without stabilizing factors.

Implications:

  • This discovery identifies a new molecular defect in plasminogen associated with thrombotic events.
  • Understanding this abnormality provides insights into the critical role of functional plasminogen activity in preventing thrombosis.
  • Further research may explore therapeutic strategies targeting fibrinolytic deficiencies.

Related Concept Videos